Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors

APMIS

Volumn 107, Issue 1, 1999, Pages 45-53

  Balbín, Milagros ^a   Pendás, Alberto M ^a   Uría, José A ^a   Jiménez, Maria G ^a   Freije, José P ^a   López Otín, Carlos ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

Breast cancer; Invasion; Metalloproteases; Metastasis

Indexed keywords

COLLAGENASE;

BASAL CELL CARCINOMA; CANCER GROWTH; CANCER INVASION; CHONDROSARCOMA; ENZYME ACTIVITY; ENZYME INDUCTION; GROWTH STIMULATION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; METASTASIS POTENTIAL; PRIORITY JOURNAL; REVIEW;

EID: 0033002928     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01525.x     Document Type: Review

References (46)

1. 1. Matrisian LM. The matrix degrading metalloproteinases. BioEssays 1992;14:455-63.
2. 2. Murphy G, Hembry RM. The matrix metalloproteinases and their inhibitors. J Rheumatol 1992;19:61-4.
3. 3. Birkedal-Hansen H, Moore WGY, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
4. 4. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541-73.
5. 5. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997;91:439-42.
6. 6. Freije JP, Diez-Itza I, Balbín M, Sánchez LM, Blasco R, Tolivia J, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269: 16766-73.
7. 7. Knäuper V, López-Otín C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544-50.
8. 8. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
9. 9. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. J Clin Invest 1996;97:2011-9.
10. 10. Wernicke D, Seyfert C, Hinzmann B, Gromnica-Ihle E. Cloning of collagenase-3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 1996;23:590-5.
11. 11. Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A, et al. MMP-13 (collagenase-3) in human rheumatoid synovium. Arthritis Rheum 1997;40:1391-9
12. 12. Stahle-Bäckdahl M, Sandsted B, Bruce K, Lindhal A, Jiménez MG, Vega JA, et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 1997;76:717-28.
13. 13. Borden P, Solymar D, Swcharczuk A, Lindman B, Cannon P, Heller RA. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes. J Biol Chem 1996;271:23577-81.
14. 14. Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 1997;94:2150-5.
15. 15. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
16. 16. Fosang AJ, Last K, Knäuper V, Murphy G, Neame PJ. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 1996;380:17-20.
17. 17. Knäuper V, Cowell S, Smith B, López-Otín C, O'Shea M, Morris H, et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997; 272:7608-16.
18. 18. Knäuper V, Will H, López-Otín C, Smith B, Atkinson SJ, Stanton H, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation: evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 1996; 271:17124-31.
19. 19. Uria JA, Stahle-Bäckdahl M, Seiki M, Fueyo A, López-Otin C. Regulation of collagenase-3 expression in breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res 1997;57:4882-8.
20. 20. MacDougall JR, Matrisian LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Met Rev 1995;14:351-62.
21. 21. Uria JA, Jiménez MG, Balbin M, Freije JP, López-Otín C. Differential effects of TGF-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J Biol Chem 1997;273:9769-77.
22. 22. Giambernardi TA, Grant GM, Taylor GP, Hay RJ, Maher VM, McCormick JJ, et al. Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol 1998;16:483-96.
23. 23. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996;149:273-82.
24. 24. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 1996;271:10079-86.
25. 25. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-70.
26. 26. Johansson N, Airola K, Grénman R, Kariniemi AL, Saarialho-Kere U, Kähäri VM. Expresion of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997; 151:499-508.
27. 27. Cazorla M, Hernández L, Nadal A, Balbín M, López JM, Vizoso F, et al. Collagenase-3 overexpression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol (1998) in press.
28. 28. Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, et al. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dynamics 1997;208:387-97.
29. 29. Uria JA, Balbin M, López JM, Alvarez J, Vizoso F, Takigawa M, et al. Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol 1998;153:91-101.
30. 30. Johansson N, Westermarck J, Leppä S, Häkkinen L. Koivisto L, López-Otin C, et al. Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor α and transforming growth factor β. Cell Growth Diff 1997; 8:243-50.
31. 31. Airola K, Johansson N, Kariniemi AL, Kähäri VM, Saarialho-Kere UK. Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 1997;109:225-31.
32. 32. Kähäri VM, Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol 1997;6:199-213.
33. 33. Cannistra SA. Cancer of the ovary. New Engl J Med 1993;18:1550-9.
34. 34. Pendás AM, Balbín M, Llano E, Jiménez MG, López-Otin C. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP-13). Genomics 1997;40:222-33.
35. 35. Collier IE, Smith J, Kronberger A, Bauer EA, Wilhelm SM, Eisen AZ, et al. The structure of the human skin fibroblast collagenase gene. J Biol Chem 1988; 263:10711-3.
36. 36. Belaaouaj A, Shipley JM, Kobayashi DK, Zimonjic DB, Popescu N, Silverman GA, et al. Human macrophage metalloelastase: genomic organization, chromosomal location, gene linkage and tissue-specific expression. J Biol Chem 1995;270:14568-75.
37. 37. Pendás AM, Matilla T, Estivill X, López-Otín C. The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family. Genomics 1995; 26:615-8.
38. 38. Pendás AM, Santamaría I, Pritchard M, Alvarez MV, López-Otín C. Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. Genomics 1996;37:266-9.
39. 39. Llano E, Pendás AM, Knäuper V, Sorsa T, Salo T, Salido E, et al. Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 1997;36:15101-8.
40. 40. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268:1749-52.
41. 41. Gutman A, Wasylyk B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 1990;9:2241-6.
42. 42. Ducy P, Karsenty G. Two distinct osteoblast-specific cisacting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 1995;15:1858-69.
43. 43. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747-54.
44. 44. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-64.
45. 45. Otto F, Thornell A, Crompton T, Denzel A, Gilmour KC, Rosewell IR, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89:765-71.
46. 46. Shorpp M, Mattel MG, Herr I, Gack S, Schaper J, Angel P. Structural organization and chromosomal localization of the mouse collagenase type I gene. Biochem J 1995;308:211-7.